Navigation Links
Impact of stem cell transplantation location in brain a crucial factor for cell survival

Putnam Valley, NY. (Feb. 13, 2013) Researchers at the Johns Hopkins University in Baltimore, Md., and the Mossakowski Medical Research Centre in Warsaw, Poland, have found that nonself-donated cells (allografts) better survive implantation into the brains of immunocompetent research mice when the grafts are injected into the striatum (STR) of the brain rather than injected into the forceps minor (FM) region. In their study, all FM grafts were rejected while STR grafts accumulated and survived along the border between the striatum and the corpus callosum.

"To the best of our knowledge, this is the first demonstration that allograft survival within the central nervous system of an immunocompetent, non-immune suppressed host may be highly dependent on implantation site," said study co-author Dr. Pior Walczak of the Johns Hopkins University School of Medicine.

The study appears as an early e-publication for the journal Cell Transplantation, and is now freely available on-line at

The researchers, who assessed the grafted cells using bioluminescence for 16 days, reported that the distribution of the FM grafts was cylindrical, parallel to the needle track, while cells transplanted to the STR accumulated along the border between the striatum and the corpus callosum in a wedge-shaped, semi lunar "pocket." They suggested that the shape of the cell deposit in the FM was likely due to damage caused by the injection procedure.

"This is an indicator that surgical injury may be the leading factor initiating the rejection process," the researchers said. "Thus, minimally traumatic allograft transplantation, preventing activation of the microglia and limiting foreign antigen presentation, may contribute to long-term allograft survival."

They commented that the STR grafts were transplanted closer to the ventricles than were the FM grafts, suggesting that the lateral ventricles "appear to present a favorable microenvironment." Additionally, they hypothesized that variability in cell survival may be related to the differences in immune responses that may exist between white matter and grey matter, as the FM is the largest region of white matter while the STR is a grey matter structure.

"Our observation that immunorejection depends on the graft implantation site has important ramifications," said Dr. Walczak. "It may account for the variability in allograft survival reported by different research groups."

The accumulation of transplanted cells in the 'pocket' between two natural bordering regions of the brain, with minimal disruption to tissue integrity, appears the most plausible explanation for the dramatic difference in the allograft rejection rate, they wrote.

They concluded that the impact of the topographical and anatomical characteristics of the target site for allografting should be carefully considered when designing cell therapies for neurological disorders at both the pre-clinical and clinical levels.


Contact: Robert Miranda
Cell Transplantation Center of Excellence for Aging and Brain Repair

Related biology news :

1. Physicians belief about obesity causes impacts advice and care
2. Climate change impacts to US coasts threaten public health, safety and economy
3. New study highlights impact of environmental change on older people
4. Going trayless study shows student impact
5. Clemson University researchers to study oil and gas operations impact on Gulf Coast pelicans
6. ImpactStory metrics of academic research outreach piloted by Pensoft Publishers
7. Study looks at gray seal impact on beach water quality
8. Ozone levels have sizeable impact on worker productivity
9. Grant funded to improve mothers nutrition before pregnancy and impact on baby
10. New online tool estimates carbon and energy impact of trees
11. Missing polar weather systems could impact climate predictions
Post Your Comments:
(Date:11/12/2015)... 12, 2015  A golden retriever that stayed healthy ... (DMD) has provided a new lead for treating this ... Broad Institute of MIT and Harvard and the University ... Cell, pinpoints a protective gene ... disease,s effects. The Boston Children,s lab of Lou ...
(Date:11/12/2015)... , Nov. 11, 2015   Growing need ... analytical tools has been paving the way for ... determination of discrete analytes in clinical, agricultural, environmental, ... being predominantly used in medical applications, however, their ... sectors due to continuous emphasis on improving product ...
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... /CNW Telbec/ - ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: ... Pierre Laurin , President and Chief Executive Officer of ProMetic, ... Jaffray 27 th Annual Healthcare Conference to be held ... st , at 8.50am (ET) and ProMetic,s ... day. The presentation will be available live via a webcast ...
(Date:11/24/2015)... and NEW YORK , November ... irst investment by Bristol-Myers Squibb in a European ... Bristol-Myers Squibb Company in which the companies will ... in immuno-oncology and other areas of unmet medical need. The ... in LSP 5, the latest LSP fund. This is the ...
(Date:11/23/2015)... OAKS, Calif., Nov. 23, 2015   Ceres, Inc ... announced today financial results for the fiscal year ended ... business. --> --> ... commercializing forage and feed products with a better balance ... company signed distribution agreements with several leading crop input ...
(Date:11/23/2015)... -- The royalty-free a greement a ... daclatasvir for 112 low- and m iddle-i ... --> The Medicines Patent Pool (MPP) today ... an agreement with Bristol-Myers Squibb for daclatasvir, a novel direct-acting ... the HCV virus.  The royalty-free licence will enable generic manufacture ...
Breaking Biology Technology: